Found 716 All Conditions trials
A listing of All Conditions medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Z
Zeruesenay Desta
What is this study about? The purpose of this study is to see how efavirenz, a widely used medication to treat HIV infection, interacts with methadone (a medication used to treat addiction problems and pain) and tizanidine (a medication used to relax muscle) when taken at the same time. The information …
N
Noel Dasgupta
This study is being done to help potentially improve or stabilize heart failure related to transthyretin amyloidosis. The plan is to administer this investigational drug (ION-682884) 45 mg subcutaneously every 4 weeks.
M
Mike Davis
We will obtain and measure exhaled VOCS in subjects with CF. We hypothesize that exhaled VOCs will differ between baseline and PEx in subjects with CF.
R
Rohan Dharmakumar
This study is a prospective, cohort study to determine the quantitative threshold differences in troponin-I level between hemorrhagic and non-hemorrhagic myocardial infarction (MI).
L
Linda DiMeglio, MD
To define the prevalence of fracture among children with T1D and T2D and compare the prevalence among the two groups of diabetes.
A
Attaya Suvannasankha, MD
What is this study about?This phase III trial compares three-drug induction regimens followed by double-or single-drug maintenance therapy for the treatment of newly diagnosed multiple myeloma in patients who are not receiving a stem cell transplant and are considered frail or intermediate-fit based on age, comorbidities, and functional status. Treatment …
M
Mythily Srinivasan
This study is being conducted to help determine whether specific proteins and other markers in saliva can predict development of taste changes, gum health and diabetes in previously coronavirus-2 infected patients with persistent symptoms or long COVID-19.
L
Linda DiMeglio, MD
What is the purpose of this study?This study is the long-term extension of the PRV-031-001 (PROTECT) study. PROTECT is a Phase 3, randomized, double-blind, placebo-controlled, multinational, multi-center study to evaluate the efficacy and safety of teplizumab, a humanized, anti-CD3 monoclonal antibody, in children and adolescents ages 8 through 17 recently …
M
Matthew Friedman, MD
The BEAM study is a multicenter, prospective, observational study in children supported on extracorporeal membrane oxygenation (ECMO). The primary goals of this study are to develop and refine a brain injury multimarker panel for accurate neurologic monitoring at the bedside and early classification of mortality and disability outcomes of critically …
M
Matthew Friedman, MD
We will measure the neurodevelopmental impact incurred by children receiving usual care ECMO for PARDS.
